Business Description
Founded in 1987 and headquartered in Melbourne, Australia, Algorae Pharmaceuticals is a drug development company focused on creating new treatments for serious conditions including dementia, Parkinson's disease, and heart disease. Its lead programs combine existing approved medicines in new ways to improve patient outcomes, while its encapsulated cell therapy product targets Parkinson's disease directly. The company is also building a drug discovery platform with the University of New South Wales that uses artificial intelligence and large-scale data analysis to identify and develop new medicines faster.
